Stimulated human melanocytes express and release interleukin-8, which is inhibited by luteolin: Relevance to early vitiligo

Clinical and Experimental Dermatology

Volumn 39, Issue 1, 2014, Pages 54-57

  Miniati, A ^a,b   Weng, Z ^a,c   Zhang, B ^a   Therianou, A ^a,b   Vasiadi, M ^a,c   Nicolaidou, E ^b   Stratigos, A J ^b   Antoniou, C ^b   Theoharides, T C ^a,c  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^c TUFTS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; LUTEOLIN; TUMOR NECROSIS FACTOR; VASCULOTROPIN;

ADULT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL CULTURE; CELL STIMULATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOREGULATION; MALE; MELANOCYTE; MICROARRAY ANALYSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REAL TIME POLYMERASE CHAIN REACTION; SKIN BIOPSY; SKIN DEFECT; VITILIGO;

ADULT; CASE-CONTROL STUDIES; CELLS, CULTURED; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION PROFILING; HUMANS; INTERLEUKIN-1BETA; INTERLEUKIN-6; INTERLEUKIN-8; LUTEOLIN; MALE; MELANOCYTES; MIDDLE AGED; SKIN; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VITILIGO;

EID: 84890560996     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/ced.12164     Document Type: Article

References (10)

1. Schallreuter KU, Bahadoran P, Picardo M, et al,. Vitiligo pathogenesis: autoimmune disease, genetic defect, excessive reactive oxygen species, calcium imbalance, or what else? Exp Dermatol 2008; 17: 139-40.
2. Aroni K, Voudouris S, Ioannidis E, et al,. Increased angiogenesis and mast cells in the centre compared to the periphery of vitiligo lesions. Arch Dermatol Res 2010; 302: 601-7.
3. Mohler T, Scheibenbogen C, Hafele J, et al,. Regulation of interleukin-8 mRNA expression and protein secretion in a melanoma cell line by tumour necrosis factor-alpha and interferon-gamma. Melanoma Res 1996; 6: 307-11.
4. Norgauer J, Dichmann S, Peters F, et al,. Tumor necrosis factor alpha induces upregulation of CXC-chemokine receptor type II expression and magnifies the proliferative activity of CXC-chemokines in human melanocytes. Eur J Dermatol 2003; 13: 124-9.
5. Luger TA, Schwarz T,. Evidence for an epidermal cytokine network. J Invest Dermatol 1990; 95: 100-4S.
6. Kempuraj D, Tagen M, Iliopoulou BP, et al,. Luteolin inhibits myelin basic protein-induced human mast cell activation and mast cell dependent stimulation of Jurkat T cells. Br J Pharmacol 2008; 155: 1076-84.
7. Zhang B, Weng Z, Sismanopoulos N, et al,. Preformed, but not de novo synthesized, TNF secretion from human mast cells is regulated by mitochondria. Int Arch Allergy Immunol 2012; 159: 23-32.
8. Toosi S, Orlow SJ, Manga P,. Vitiligo-inducing phenols activate the unfolded protein response in melanocytes resulting in upregulation of IL-6 and IL-8. J Invest Dermatol 2012; 132: 2601-9.
9. Middleton EJ, Kandaswami C, Theoharides TC,. The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease and cancer. Pharmacol Rev 2000; 52: 673-751.
10. Nagata H, Takekoshi S, Takeyama R, et al,. Quercetin enhances melanogenesis by increasing the activity and synthesis of tyrosinase in human melanoma cells and in normal human melanocytes. Pigment Cell Res 2004; 17: 66-73.